Research Paper Volume 16, Issue 7 pp 6098—6117
The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma
Figure 4. Assessment of the risk prognostic model associated with necroptosis-lncRNAs. (A) The uni-Cox analyses of clinical factors and risk score with OS. (B) The multi-Cox analyses of clinical factors and risk score with OS. (C) The 1-, 3-, and 5-year ROC curves. (D) The ROC curves of prognosis-related parameters. (E) The survival analysis of patients in the early stages (stages I, II). (F) The survival analysis of patients in the advanced stages (stage III, IV). (G) The nomogram of age, gender, risk score, and TNM staging. (H) The calibration curves for 1-, 3-, and 5-year OS. ROC, receiver operating characteristic; AUC, area under the curve; T, tumor; N, node; M, metastasis; OS, overall survival. * P < 0.05; ** P < 0.01; *** P < 0.001.